| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Prairie Operating Co. | Director | Common Stock | 1.14M | $5.72M | $5.00 | 03 May 2023 | Direct |
| GT Biopharma, Inc. | CEO and Director, Director | Option to purchase Common Stock | 100K | 04 Sep 2025 | Direct | ||
| Prairie Operating Co. | Director | Stock Option (Right to Buy | 67.5K | 03 Aug 2020 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GTBP | GT Biopharma, Inc. | 04 Sep 2025 | 3 | $0 | 4 | CEO and Director, Director | 08 Sep 2025, 17:45 |
| GTBP | GT Biopharma, Inc. | 11 Aug 2023 | 1 | $57.4K | 4 | Executive Chairman/Interim CEO, Director | 15 Aug 2023, 20:29 |
| CRKR | Prairie Operating Co. | 03 May 2023 | 5 | $138K | 4 | Director | 05 May 2023, 21:43 |
| GTBP | GT Biopharma, Inc. | 11 Apr 2023 | 1 | $25K | 4 | Executive Chairman/Interim CEO, Director | 11 Apr 2023, 18:59 |
| GTBP | GT Biopharma, Inc. | 27 Jan 2023 | 1 | $0 | 4 | Exec Chairman and Interim CEO, Director | 01 Feb 2023, 05:05 |
| GTBP | GT Biopharma, Inc. | 15 Jul 2022 | 2 | $0 | 4 | Exec. Chair. and Interim CEO, Director | 19 Jul 2022, 21:48 |
| GTBP | GT Biopharma, Inc. | 16 Feb 2021 | 6 | $170K | 4 | Director | 12 Nov 2021, 11:01 |
| GTBP | GT Biopharma, Inc. | 13 Jan 2021 | 0 | $0 | 3 | Director | 12 Nov 2021, 11:01 |